Abstract Nkx2.2 is a homeobox transcription factor that is expressed in the pancreas, intestine and central nervous system (CNS) during embryogenesis and in the adult. In mice, global deletion of Nkx2.2 results in cell mis-specification in each of the tissues where it is expressed, and the null mice die as neonates with severe hyperglycemia. Although a whole body knockout demonstrates the importance of Nkx2.2 in cell specification and postnatal viability, it precludes assessment of the cell-autonomous and postnatal functions of Nkx2.2. In this study we report the generation and functional characterization of mice encoding a conditional allele of Nkx2.2. We demonstrate the functional integrity of the conditional Nkx2.2 allele and report successful in vivo deletion using a pancreas-specific Cre recombinase. The pancreasspecific deletion of Nkx2.2 results in similar defects found in the Nkx2.2 null pancreas and the mice die shortly after birth, demonstrating that the neonatal lethality associated with the null allele is caused by pancreatic islet dysfunction. The generation of a conditional Nkx2.2 allele provides an important tool for identifying the cell-autonomous and postnatal activities of Nkx2.2 in establishing and maintaining cell type identities and functions in the pancreas, intestine and CNS.
Introduction
Nkx2.2 is a homeodomain-containing transcription factor expressed in the pancreas, intestine and central nervous system (CNS) (Arnes et al. 2012 ). In the pancreas, Nkx2.2 is expressed throughout the epithelium of the developing pancreatic buds, beginning at embryonic day (E) 8.75 (Jorgensen et al. 2007 ). As pancreatic development proceeds, Nkx2.2 remains expressed in a population of ductal cells, as well as specific endocrine cell subtypes. In the postnatal pancreas, Nkx2.2 becomes restricted to insulin-producing beta cells, glucagon-producing alpha cells, ghrelin-producing epsilon cells, and pancreatic polypeptide-producing PP cells (Arnes et al. 2012; Prado et al. 2004; Sussel et al. 1998) .
Global deletion of Nkx2.2 in the mouse results in dramatic alterations to the complement of hormoneproducing islet cells in the pancreas. Specifically, beta cells are absent, alpha and PP cells are reduced, and epsilon cells are concomitantly increased (Prado et al. 2004; Sussel et al. 1998) . As a result of these defects, the mice are hyperglycemic at birth and die within the first week of postnatal life. In addition to the pancreatic defects, cell specification in the intestine and CNS are also affected by deletion of Nkx2.2. Similar to the pancreas, intestinal enteroendocrine cells are formed in altered ratios; ghrelin cells are dramatically increased with a corresponding decrease in many of the other enteroendocrine populations, including those expressing serotonin, somatostatin and GIP (Desai et al. 2008) . Moreover, several neuronal cell populations are re-specified in the developing CNS (Briscoe et al. 1999; Qi et al. 2001 ). Due to the early postnatal lethality associated with the Nkx2.2 null allele, we were unable to determine the physiological consequences of the intestinal and CNS phenotypes. Furthermore, the early lethality associated with these mice precluded analysis of any postnatal functions of Nkx2.2 in each of the tissues where it is expressed.
To determine the tissue-specific and postnatal functions of Nkx2.2, we have used a gene targeting approach to generate Nkx2.2 conditional knockout mice. We have determined that the inducible allele does not disrupt normal Nkx2.2 function. Moreover, when the Nkx2.2 flox allele is homozygosed and combined with Pdx1-cre deleter mice (Hingorani et al. 2003) , Nkx2.2 is efficiently deleted in the pancreas and the Nkx2.2 null islet phenotype is recapitulated. Furthermore, these mice die with hyperglycemia shortly after birth, confirming that the early postnatal lethality is primarily caused by the pancreatic defects.
Materials and methods
Generation of mice encoding a conditional allele of Nkx2.2 A loxP site (L83) and a FNFL cassette (FRT-Neo-FRTLoxP) were engineered to flank exon 2 (E2) of the Nkx2.2 gene to generate the Nkx2.2 conditional targeting construct on a bacterial artificial chromosome (BAC). The gene targeting vector was generated by retrieving a 10 kb long homology arm (5 0 end to L83), floxed sequence containing exon 2, FNFL cassette, and 2 kb short homology arm (end of FNFL to 3 0 end) into a vector carrying the Diphtheria toxin alpha chain (DTA) negative selection marker. ; Pdx1-cre mutants and littermate controls were assessed at E15.5 and postnatal day (P) 1. All experiments involving mice were approved by the Columbia University Institutional Animal Care and Use Committee and performed in accordance with the National Institutes of Health guidelines for the care and use of animals.
For genotyping, a portion of embryonic or postnatal tail was removed, digested with proteinase K, and DNA extracted. Previously described conditions and primers were used to genotype for Pdx1-cre (Hingorani et al. 2003) . Genotyping for the Nkx2.2 flox allele was carried out using two sets of primers: L83-forward:
0 . An initial denaturation at 94°C for 5 min was used, followed by 35 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 1 min, and a final extension of 72°C for 5 0 . The L83 primer set produced two possible amplification products of 397 bp (wildtype) and 480 bp (Nkx2.2 flox ); the FL146 primer set produced two possible amplification products of 420 bp (wildtype) and 566 bp (Nkx2.2 flox ).
Metabolic analyses
Animals were maintained on a normal chow diet, and body weight was measured weekly using a standard scale. Blood glucose measurements were obtained with an Accu-Check Compact Plus glucose monitor (Model GT; Roche). Glucose tolerance tests (GTT) were performed after an overnight fast, as previously described (Banks et al. 2011 ).
Immunofluorescence
Immunofluorescence was performed according to previously published protocols, on pancreas sections from E15.5 embryos and postnatal pancreas tissue (P0 and P14) (Mastracci et al. , 2013 . In all cases, tissue was embedded in OCT, after fixation with 4 % PFA and cryopreservation in 30 % sucrose. Frozen sections (8 lm) were cut and mounted on glass slides. Sections were stained with goat a-ghrelin (1:800; Santa Cruz), guinea pig a-glucagon (1:1,000; Linco/ Millipore, MA), guinea pig a-insulin (1:1,000; Millipore), rabbit a-insulin (1:1,000; Cell Signaling Technology), rabbit a-somatostatin (1:200; Phoenix Pharmaceuticals), rabbit a-pancreatic polypeptide (1:200; Zymed) and rabbit a-amylase (1:1,000; Sigma). Donkey a-guinea pig-Cy2, -Cy3 or -Cy5, arabbit-Cy2 or -Cy3, and a-goat Cy2 or -Cy5 secondary antibodies were used (1:400, Jackson ImmunoResearch). DAPI (1:1,000; Invitrogen) was applied for 30 min following secondary antibody incubation. Images were acquired on a Leica DM5500. ; Pdx1-cre at E15.5.
Real time PCR
Pancreas was dissected from each embryo and stored in RNAlater (Ambion) until RNA was extracted using the NucleoSpin RNAII Kit (Clontech). Subsequently, cDNA was made with equal amounts of RNA for each sample (Superscript III Kit, Invitrogen, CA). Real time PCR was performed using TaqMan gene expression assays-on-demand (Applied Biosystems) for glucagon
pancreatic polypeptide (Mm00435889_m1) and somatostatin (Mm00436671_m1). CyclophilinB was used as a control housekeeping gene, and was assayed using a probe and primer set previously described (Anderson et al. 2009 ). Nkx2.2 was also assayed with a probe and primer set previously described (Anderson et al. 2009 ). Statistical analyses were conducted with Prism Software (GraphPad Software, La Jolla, CA) using a standard t test.
Results and discussion
To generate a conditional allele of Nkx2.2, loxP sites were introduced into the Nkx2.2 genomic locus, flanking exon 2. The 5 0 loxP site was positioned within intron 1 and the 3 0 loxP site and Neomycin cassette were inserted into a non-conserved region of the 3 0 UTR (Fig. 1a) . The construct was electroporated into 129/B6 hybrid PTL1 ES cells. 192 colonies were screened by PCR, using primers from within the construct sequence to a genomic region located (b) embryos at E15.5, whereas a significant decrease of alpha cells was observed in the Nkx2.2 flox/flox ; Pdx1-cre pancreas (c). The known pattern of expression for Nkx2.2 was observed in the control pancreas sections (d, e) compared with the efficient loss of Nkx2.2 in the mutant (f) due to Pdx1-cre mediated recombination of the Nkx2.2 flox allele. Similar to the phenotype observed in the Nkx2.2 null mice, pups were born and had severely elevated blood glucose (g). DAPI marks nuclei (a-c). Images are 920 outside the sequences included in the construct (Fig. 1b) . Five positive Nkx2.2 flox -targeted ES clones were identified and clone 9G was used to generate mice. Mating of chimeras for germline transmission and removal of the Neomycin cassette occurred simultaneously using mice expressing FLP recombinase on a B6 background (B6; SJL-Tg(ACTFLPe)9205Dym/J (ACTB FLPe/FLPe ). Two founder lines were identified (CKO line A and CKO line B).
Nkx2.2 antisense
Both lines of Nkx2.2 flox/? animals were viable and fertile, and when the allele was homozygosed (Fig. 1c) no alteration to breeding/fertility was observed. CKO line A was used for all subsequent analysis.
To ensure that the presence of flanking lox sites within the Nkx2.2 genomic locus did not adversely affect Nkx2.2 function, mice carrying the Nkx2.2 flox allele were mated for homozygosity and analyzed for pancreatic/metabolic function. Males and females were followed from weaning (3 weeks) to adult (12 weeks), and no change in body weight was observed in Nkx2.2 flox/flox compared with both Nkx2.2 flox/? and wildtype mice (Fig. 2a, b) . Moreover, males and females at weaning age (3 weeks) were fasted overnight and then subjected to an intraperitoneal GTT. Following glucose injection, blood glucose was measured at timed intervals over 120 min. Glucose clearance was unaltered in Nkx2.2 flox/flox mice compared with controls ( Fig. 2c, d) ; area under the curve shows no significant difference (Fig. 2e) . Mice subjected to GTT were of similar weight (Fig. 2f) , and blood glucose before fasting was not different between genotypes (Fig. 2g) .
Pancreas tissue was analyzed during development and postnatally to determine that all hormone-expressing cells were present and islet morphology was unaltered. At E15.5, P0 and 2 weeks of age, the complement of hormone-expressing cells appeared unaltered between wildtype and Nkx2.2 flox/flox animals (Fig. 3) . In addition, islet morphology displayed the expected structure of a core of insulin-producing beta cells surrounded by glucagon-, ghrelin-, somatostatin-, and PP-expressing cells (Fig. 3m-r) .
To test that Nkx2.2 could be deleted efficiently, Nkx2.2 flox mice were bred to Pdx1-cre transgenic mice to produce mice with a deletion of Nkx2.2 in all Pdx1-expressing cells, which includes the entire pancreatic domain. Embryos were harvested at E15.5 and the pancreas was analyzed using RNA in situ hybridization for the presence of Nkx2.2 transcript. Whereas the expected expression pattern of Nkx2.2 was observed in wildtype and Nkx2.2 flox/flox pancreas, pancreatic tissue from Nkx2.2 flox/flox ; Pdx1-cre embryos was devoid of Nkx2.2 (Fig. 4a-e) . Moreover, Nkx2.2 flox/flox ; Pdx1-cre animals were born but died within the first week of life; pups analyzed at P1 displayed elevated blood glucose levels (Fig. 4g) beta cells (Sussel et al. 1998) . Given this similarity, Nkx2.2 flox/flox ; Pdx1-cre mutant embryos were further analyzed to determine if the islet cell phenotype of the Nkx2.2 null was recapitulated in the Nkx2.2 flox/flox ; Pdx1-cre mutants. As expected, ghrelin (Ghr) was dramatically increased in the Nkx2.2 flox/flox ; Pdx1-cre compared with wildtype (Fig. 5a ). Nkx2.2 was expectedly decreased, along with insulin1 (Ins1), insulin2 (Ins2), glucagon (Gcg), and pancreatic polypeptide (Ppy) transcript; somatostatin (Sst) expression was unchanged (Fig. 5a) . Moreover, pancreas tissue from E15.5 embryos was analyzed by immunofluorescence and the observed cellular phenotype recapitulated the expression data and phenocopied the Nkx2.2 null embryos ( Fig. 5b-e) .
Altogether these data demonstrate that the Nkx2. ; Pdx1-cre mutant animals recapitulate the pancreatic phenotype associated with the whole body deletion of Nkx2.2 (Prado et al. 2004; Sussel et al. 1998) . These studies also confirm that the neonatal lethality associated with the Nkx2.2 null mice is due to loss of Nkx2.2 activity in the pancreas. The generation of this conditional allele of Nkx2.2 facilitates further analysis of the cell-autonomous and stage-specific functions of Nkx2.2 in the pancreas, intestine and CNS.
